Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Statistical Methods in Medical Research|June 18, 2025
Response adaptive randomisation in clinical trials: Current practice, gaps and future directionsIsabelle Wilson, Steven Julious, Christina Yap, et al.
Pharmacoeconomics|February 20, 2019
Correction to: Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case StudyMatthew Franklin, Sarah Davis, Michelle Horspool, et al.
Forensic Science International|July 9, 2004
Has the cocaine epidemic arrived in the UK?Steve George
Clinical Chemistry and Laboratory Medicine|December 4, 2004
Position of immunological techniques in screening in clinical toxicologySteve George
Pharmacoeconomics|January 23, 2017
Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case StudyMatthew Franklin, Sarah Davis, Michelle Horspool, et al.
Trials|June 22, 2024
A proposal for using benefit-risk methods to improve the prominence of adverse event results when reporting trialsNikki Totton, Ed Waddingham, Ruth Owen, et al.
Primary Health Care Research & Development|February 10, 2016
PPI in the PLEASANT trial: involving children with asthma and their parents in designing an intervention for a randomised controlled trial based within primary careJonathan Boote, Steven Julious, Michelle Horspool, et al.
BMC Medical Research Methodology|June 5, 2025
Value-adaptive clinical trial designs for efficient delivery of publicly funded trials - a discussion of methods, case studies, opportunities and challengesLaura Flight, Alan Brennan, Stephen E Chick, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2019
A Review of Clinical Trials With an Adaptive Design and Health Economic AnalysisLaura Flight, Fahid Arshad, Rachel Barnsley, et al.
Pharmaceutical Statistics|February 27, 2010
Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trialsJames Matcham, Steven Julious, Stephen Pyke, et al.
Pageof 8